Placeholder Banner

BIO letter in support of H.R. 5418

March 10, 2016

Dear Representative Issa:

I write on behalf of the Biotechnology Industry Organization (BIO) to commend your sponsorship of, and express our support for, H.R. 5418, which would establish a pilot program in certain United States district courts to enhance the education and expertise of district court judges in the areas of patent law.

Download Full Comments Below
20060614
Read the letter
Discover More
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a…
On August 6, BIO submitted comments on the NMPA Draft Technical Guideline on Clinical Trials of Cellular Immunotherapy Products. In the comments, BIO thanks NMPA for the opportunity to submit comments but argues for a more robust commenting period…
October 30, 2020 Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Dear Sir/Madam: The Biotechnology…